Cited 22 times in
Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.